Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neisseria Lactamica Nasal Inoculation With Eradication on Day 4 or 14
NCT03549325Terminated
- Sponsor
- University Hospital Southampton NHS Foundation Trust
- Start
- Mar 2017
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Open-label trial of Neisseria lactamica in meningococcal meningitis (2 arms), sponsored by University Hospital Southampton NHS Foundation Trust. Primary endpoint: Serological Antibody Titration up to 42 Days. Started Mar 2017; status: terminated.
02
Drugs
Neisseria lactamica
03
Conditions
meningococcal meningitis
Beyond the preview
Go deeper on NCT03549325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03549325.